Brain magnetic resonance imaging review suggests unrecognised hypoglycaemia in childhood

Chris Worth1, Pon Ramya Gokul1, Katie Ramsden1

  • 1Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, United Kingdom.

PubMed

Insights

Unrecognized early-life hypoglycemia can lead to brain injury, detectable via MRI. This study found evidence of missed hypoglycemic events in children, emphasizing the need for increased awareness to prevent neurological damage.

Area of Science:

  • Pediatric Neurology
  • Neuroradiology
  • Neonatal Medicine

Background:

  • Neonatal and early-life hypoglycemia is common but often asymptomatic, complicating diagnosis.
  • Hypoglycemia can cause brain injury, evidenced by specific MRI findings in white matter and posterior brain regions.
  • The occurrence of brain injury from unrecognized early-life hypoglycemia in children is not well understood.

Purpose of the Study:

  • To investigate the presence of brain injury resulting from unrecognized early-life hypoglycemic events in children.
  • To examine retrospective neuroimaging findings for evidence of past missed hypoglycemic episodes.

Main Methods:

  • Retrospective review of MRI reports over ten years from a single tertiary center.
  • Searched electronic radiology repository for "hypoglycemia" and reviewed relevant images and reports.
  • Assessed medical records to determine if hypoglycemia was diagnosed before imaging.

Main Results:

  • 107 MRI reports were reviewed; 52 (48.5%) showed features suggestive of hypoglycemic brain injury.
  • In 22 (42%) of these cases, medical records lacked prior hypoglycemia diagnosis, indicating potential missed events.
  • Findings suggest a significant proportion of hypoglycemic brain injury may stem from unrecognized early-life events.

Conclusions:

  • This study confirms the existence of unrecognised childhood hypoglycemia leading to brain injury, identified through neuroimaging.
  • Highlights the critical need for increased clinical awareness of early-life hypoglycemia.
  • Emphasizes proactive identification and management to prevent long-term adverse neurological outcomes in children.
Abstract

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...